Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Change in Acquisitions & Divestments (2020 - 2026)

Viatris (VTRS) posted Change in Acquisitions & Divestments of $400.0 million for Q1 2026, up 6796.55% on a QoQ basis from $5.8 million in Q4 2025, and up 8595.65% year-over-year from $4.6 million in Q1 2025.

Analysis

Viatris (VTRS) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends

Viatris has reported Change in Acquisitions & Divestments for 7 years, with the latest figure at $400.0 million in Q1 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 8595.65% year-over-year to $400.0 million in Q1 2026; TTM through Jun 2026 was $413.0 million, a 1650.0% increase from a year earlier, with the FY2025 full-year figure at $23.9 million, down 8.08% from the prior year.
  • Change in Acquisitions & Divestments was $400.0 million for Q1 2026 at Viatris, up from $5.8 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $400.0 million in Q1 2026, with the low at $4.3 million in Q3 2023.
  • Average Change in Acquisitions & Divestments over 5 years is $29.8 million, with a median of $6.9 million recorded in 2022.
  • The sharpest annual moves came in 2023 and 2026: Change in Acquisitions & Divestments sank 57.84% in 2023, then surged 8595.65% in 2026.
  • Over 5 years, Change in Acquisitions & Divestments stood at $6.9 million in 2022, then decreased by 21.74% to $5.4 million in 2023, then fell by 20.37% to $4.3 million in 2024, then surged by 34.88% to $5.8 million in 2025, then surged by 6796.55% to $400.0 million in 2026.
  • The last three Change in Acquisitions & Divestments figures came in at $400.0 million (Q1 2026), $5.8 million (Q4 2025), and $7.2 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 400.00 Mn
Dec 31, 2025 5.80 Mn
Sep 30, 2025 7.20 Mn
Jun 30, 2025 6.30 Mn
Mar 31, 2025 4.60 Mn
Dec 31, 2024 4.30 Mn
Sep 30, 2024 8.40 Mn
Jun 30, 2024 5.60 Mn
Mar 31, 2024 7.70 Mn
Dec 31, 2023 5.40 Mn
Sep 30, 2023 4.30 Mn
Jun 30, 2023 7.60 Mn
Mar 31, 2023 9.00 Mn
Dec 31, 2022 6.90 Mn
Sep 30, 2022 10.20 Mn
Jun 30, 2022 4.30 Mn
Mar 31, 2022 8.50 Mn
Dec 31, 2021 3.80 Mn
Sep 30, 2021 6.80 Mn
Jun 30, 2021 6.90 Mn